INS and metabolic syndrome: Dietary n-3 PUFAs, especially long-chain n-3 PUFAs, including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), have anti-inflammatory and antioxidant properties, which improve insulin resistance and lipid metabolism and ameliorate obesity and dyslipidemia [21,22].